WTNA
TOVX icon

Wilmington Trust National Association’s Theriva Biologics TOVX Stock Holding History

Wilmington Trust National Association’s Portfolio TOVX Stock Details TOVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		$63K Hold
4
– – ﹤0.01% 604
2014
Q1 		$94K Hold
4
– – ﹤0.01% 583
2013
Q4 		$56K Hold
4
– – ﹤0.01% 549
2013
Q3 		$61K Hold
4
– – ﹤0.01% 552
2013
Q2 		$63K Buy
+4
New +$54.7K ﹤0.01% 532

Other funds holding TOVX

TS
Third Security Radford, Virginia $241M AUM 45.43% 1-Year Est. Return
MP
MSD Partners New York $82.3M AUM 15.13% 1-Year Est. Return
KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
TC
TFS Capital West Chester, Pennsylvania $255M AUM 32.31% 1-Year Est. Return
Janney Montgomery Scott
Janney Montgomery Scott Philadelphia, Pennsylvania $40.4B AUM 21.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wilmington Trust National Association's TOVX Position: Q2 2014 in Review

Wilmington Trust National Association held its Theriva Biologics (TOVX) position steady in Q2 2014 at 4 shares worth $63K. The position accounts for ﹤0.01% of the portfolio, ranked #604.

Wilmington Trust National Association first reported a position in TOVX in Q2 2013 and has held it in 5 quarters since. The position peaked at $94K in Q1 2014. 26 funds tracked by Wall St. Rank hold TOVX as of Q2 2014.

  • Wilmington Trust National Association held 4 shares of Theriva Biologics worth $63K as of Q2 2014.
  • Wilmington Trust National Association left its Theriva Biologics share count unchanged in Q2 2014.
  • Theriva Biologics made up ﹤0.01% of Wilmington Trust National Association's portfolio in Q2 2014, its #604 holding.
  • Wilmington Trust National Association first reported a position in Theriva Biologics in Q2 2013 and has held it in 5 quarters since.
  • Wilmington Trust National Association's Theriva Biologics position peaked at $94K in Q1 2014.
  • 26 funds tracked by Wall St. Rank held Theriva Biologics as of Q2 2014.

Based on Wilmington Trust National Association's 13F filing for Q2 2014, filed 13 Aug 2014.